SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 161 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,931 | +20.8% | 18,550 | -1.0% | 0.02% | +13.3% |
Q1 2024 | $2,426 | +37.1% | 18,737 | +2.1% | 0.02% | +25.0% |
Q4 2023 | $1,769 | -35.2% | 18,347 | -18.5% | 0.01% | -33.3% |
Q3 2023 | $2,728 | +17.4% | 22,508 | +10.9% | 0.02% | +12.5% |
Q2 2023 | $2,323 | -30.8% | 20,288 | -16.6% | 0.02% | -30.4% |
Q1 2023 | $3,355 | +9.9% | 24,338 | +3.3% | 0.02% | +4.5% |
Q4 2022 | $3,052 | -99.9% | 23,554 | -13.5% | 0.02% | 0.0% |
Q3 2022 | $3,009,000 | +205.2% | 27,224 | +106.9% | 0.02% | +214.3% |
Q2 2022 | $986,000 | -26.6% | 13,158 | -23.5% | 0.01% | 0.0% |
Q1 2022 | $1,343,000 | +3.8% | 17,195 | +19.6% | 0.01% | +16.7% |
Q4 2021 | $1,294,000 | +18.9% | 14,375 | +22.1% | 0.01% | 0.0% |
Q3 2021 | $1,088,000 | +44.7% | 11,770 | +21.7% | 0.01% | +50.0% |
Q2 2021 | $752,000 | -47.9% | 9,672 | -50.1% | 0.00% | -50.0% |
Q1 2021 | $1,444,000 | -53.3% | 19,371 | +6.9% | 0.01% | -57.9% |
Q4 2020 | $3,091,000 | +74.5% | 18,128 | +43.8% | 0.02% | +72.7% |
Q3 2020 | $1,771,000 | -63.0% | 12,608 | -57.8% | 0.01% | -71.8% |
Q2 2020 | $4,786,000 | +465.1% | 29,849 | +244.9% | 0.04% | +333.3% |
Q1 2020 | $847,000 | -25.0% | 8,655 | -1.2% | 0.01% | 0.0% |
Q4 2019 | $1,130,000 | +71.7% | 8,757 | +0.2% | 0.01% | +50.0% |
Q3 2019 | $658,000 | -44.3% | 8,742 | +19.4% | 0.01% | -25.0% |
Q3 2018 | $1,182,000 | -28.2% | 7,320 | -41.2% | 0.01% | -20.0% |
Q2 2018 | $1,646,000 | +63.8% | 12,450 | -8.2% | 0.01% | +42.9% |
Q1 2018 | $1,005,000 | -12.0% | 13,566 | -33.9% | 0.01% | -12.5% |
Q4 2017 | $1,142,000 | +414.4% | 20,528 | +319.2% | 0.01% | +700.0% |
Q3 2017 | $222,000 | -23.2% | 4,897 | +3.9% | 0.00% | -50.0% |
Q3 2016 | $289,000 | +151.3% | 4,712 | -21.9% | 0.00% | +100.0% |
Q2 2016 | $115,000 | +10.6% | 6,034 | +13.6% | 0.00% | 0.0% |
Q1 2016 | $104,000 | -31.1% | 5,310 | +35.5% | 0.00% | 0.0% |
Q4 2015 | $151,000 | -2.6% | 3,918 | -18.9% | 0.00% | 0.0% |
Q3 2015 | $155,000 | +229.8% | 4,833 | +216.1% | 0.00% | – |
Q2 2015 | $47,000 | +193.8% | 1,529 | +28.6% | 0.00% | – |
Q1 2015 | $16,000 | -5.9% | 1,189 | +0.9% | 0.00% | – |
Q4 2014 | $17,000 | -41.4% | 1,178 | -14.9% | 0.00% | – |
Q3 2014 | $29,000 | -27.5% | 1,385 | +3.4% | 0.00% | – |
Q2 2014 | $40,000 | +25.0% | 1,340 | 0.0% | 0.00% | – |
Q1 2014 | $32,000 | +33.3% | 1,340 | +12.7% | 0.00% | – |
Q4 2013 | $24,000 | -86.9% | 1,189 | -69.3% | 0.00% | -100.0% |
Q3 2013 | $183,000 | +134.6% | 3,873 | +88.0% | 0.00% | +100.0% |
Q2 2013 | $78,000 | – | 2,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |